WT1 and non-small cell lung carcinoma: The chi-squared test showed that expression levels of WT1-AS and TGF-β1 mRNA were significantly correlated with the clinical stage (p < 0.05), but not subtypes of NSCLC (p > 0.05) and smoking history (p > 0.05).